TOKYO--(BUSINESS WIRE)--$INCY--Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for...

TOKYO--(BUSINESS WIRE)--$INCY--Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for...

A new three-drug immunotherapy combination significantly improves outcomes for relapsed follicular lymphoma, offering a chemotherapy-free treatment...

A new three-drug immunotherapy combination significantly improves outcomes for relapsed follicular lymphoma, offering a chemotherapy-free treatment...

MONDAY, Dec. 29, 2025 -- For adults with acute leukemia (AL) undergoing hematopoietic stem cell transplant (HSCT) or induction chemotherapy, a more...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia...

New AI-powered research tool, named bCORAL, reads standard biopsy slides and immediately predicts patient outcomes in medlinkplasma cell oncology...

New AI-powered research tool, named bCORAL, reads standard biopsy slides and immediately predicts patient outcomes in medlinkplasma cell oncology...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at...

Conventional pancreatic cancer treatments face a critical hurdle due to the dense tumour microenvironment (TME). This biological barrier surrounds the...